Literature DB >> 30706134

The treatment of amblyopia: current practice and emerging trends.

Eleni Papageorgiou1,2, Ioannis Asproudis3, Gail Maconachie4, Evangelia E Tsironi5, Irene Gottlob4.   

Abstract

PURPOSE: The purpose of this review is to provide an update on current management and recent research for amblyopia treatment. Part I will review patching, atropine penalization, and pharmacological treatments. Part II will focus on perceptual learning, video gaming, and binocular dichoptic approaches.
METHODS: A literature search was performed in PubMed, ClinicalTrials.gov , Google Scholar, and reference lists of retrieved articles until December 20, 2018, for all papers containing "amblyopia treatment" or "amblyopia therapy." We have included RCTs, prospective observational studies, prospective and retrospective cohort studies, pilot studies, and review articles.
RESULTS: The mainstay of treatment for amblyopia has been based on increasing visual stimulation of the amblyopic eye by occlusion, atropine, or optical penalization of the dominant eye. It has been established that refractive adaptation alone can significantly enhance visual acuity. However, the duration of optical correction varies between studies and the effectiveness of spectacle wear over early beginning of patching is still under investigation. Additionally, by means of occlusion dose monitors, it was found that adherence to occlusion affects the outcome, as a dose-response relationship exists between adherence and visual acuity. Treatment efficiency declines with age; however, recent evidence indicates cortical plasticity beyond the "critical period" and recommends that an attempt at treatment should be offered to all amblyopic children regardless of age, including those in later childhood. Novel approaches targeted to the restoration of binocular functions, such as perceptual learning, video gaming, and dichoptic training, have shown small effects on visual acuity and have failed to demonstrate non-inferiority over standard treatments.
CONCLUSIONS: On review, significant evidence for the successful management of amblyopia, with occlusion therapy and atropine, has been found. However, the management of amblyopia remains challenging, mainly due to compliance issues and suboptimal treatment outcomes during occlusion and atropine penalization. Recent studies have found evidence of new ways of treating amblyopia particularly in regard to binocular treatment although these remain under investigation. Further robust clinical trials on these new treatment modalities are still warranted in order to establish their role in treating amblyopia.

Entities:  

Keywords:  Amblyopia; Atropine; Dichoptic training; Occlusion; Perceptual learning; Video gaming

Mesh:

Substances:

Year:  2019        PMID: 30706134     DOI: 10.1007/s00417-019-04254-w

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  189 in total

1.  Cytidine-5'-diphosphocholine (citicoline) improves retinal and cortical responses in patients with glaucoma.

Authors:  V Parisi; G Manni; G Colacino; M G Bucci
Journal:  Ophthalmology       Date:  1999-06       Impact factor: 12.079

2.  Occlusion and levodopa-carbidopa treatment for childhood amblyopia.

Authors:  L E Leguire; G L Rogers; P D Walson; D L Bremer; M L McGregor
Journal:  J AAPOS       Date:  1998-10       Impact factor: 1.220

3.  Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation.

Authors:  M A Nitsche; W Paulus
Journal:  J Physiol       Date:  2000-09-15       Impact factor: 5.182

4.  Poverty predicts amblyopia treatment failure.

Authors:  D T Hudak; E H Magoon
Journal:  J AAPOS       Date:  1997-12       Impact factor: 1.220

5.  Psychosocial and clinical determinants of compliance with occlusion therapy for amblyopic children.

Authors:  A Searle; P Norman; R Harrad; K Vedhara
Journal:  Eye (Lond)       Date:  2002-03       Impact factor: 3.775

6.  Successful amblyopia therapy initiated after age 7 years: compliance cures.

Authors:  H A Mintz-Hittner; K M Fernandez
Journal:  Arch Ophthalmol       Date:  2000-11

7.  Parental non-concordance with occlusion therapy.

Authors:  D Newsham
Journal:  Br J Ophthalmol       Date:  2000-09       Impact factor: 4.638

8.  A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children.

Authors: 
Journal:  Arch Ophthalmol       Date:  2002-03

9.  A randomised controlled trial of written information: the effect on parental non-concordance with occlusion therapy.

Authors:  D Newsham
Journal:  Br J Ophthalmol       Date:  2002-07       Impact factor: 4.638

10.  Visual acuities after levodopa administration in amblyopia.

Authors:  K Mohan; V Dhankar; A Sharma
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2001 Mar-Apr       Impact factor: 1.402

View more
  12 in total

1.  New treatment for amblyopia based on rules of synaptic plasticity: a randomized clinical trial.

Authors:  Xin Huang; Huika Xia; Qi Zhang; Yan Nan; Wenyao Wang; Colin Blakemore; Jie Gao; Spencer S Ng; Jing Wen; Tiejun Huang; Xiaoqing Li; Mingliang Pu
Journal:  Sci China Life Sci       Date:  2022-01-06       Impact factor: 6.038

2.  A Randomized Trial of Binocular Dig Rush Game Treatment for Amblyopia in Children Aged 4 to 6 Years.

Authors:  Ruth E Manny; Jonathan M Holmes; Raymond T Kraker; Zhuokai Li; Amy L Waters; Krista R Kelly; Lingkun Kong; Earl R Crouch; Ingryd J Lorenzana; Maan S Alkharashi; Jennifer A Galvin; Melissa L Rice; B Michele Melia; Susan A Cotter
Journal:  Optom Vis Sci       Date:  2022-03-01       Impact factor: 1.973

3.  A randomized study of network-based perception learning in the treatment of amblyopia children.

Authors:  Chang-Yue Zheng; Wei Xu; Shun-Qiang Wu; Dong-Xu Han
Journal:  Int J Ophthalmol       Date:  2022-05-18       Impact factor: 1.645

4.  Regional Downregulation of Dopamine Receptor D1 in Bilateral Dorsal Lateral Geniculate Nucleus of Monocular Form-Deprived Amblyopia Models.

Authors:  Dongyue Lin; Zhonghao Wang; Wei Chen; Tao Shen; Xuan Qiu; Kun Wei; Jiahui Li; Dongsheng Yang; Ping Wang; Xuri Li; Jianhua Yan; Zhongshu Tang
Journal:  Front Neurosci       Date:  2022-06-08       Impact factor: 5.152

Review 5.  An update on pharmacological treatment options for amblyopia.

Authors:  Aldo Vagge; Lorenzo Ferro Desideri; Carlo Enrico Traverso
Journal:  Int Ophthalmol       Date:  2020-08-07       Impact factor: 2.031

6.  Emerging therapies for amblyopia.

Authors:  Michelle M Falcone; David G Hunter; Eric D Gaier
Journal:  Semin Ophthalmol       Date:  2021-03-03       Impact factor: 1.975

7.  A Randomized Clinical Trial Comparing Eyetronix Flicker Glass and Patching for Treatment of Amblyopia in Children Reveals Similar Improvements in Vision.

Authors:  Seung Hyun Min; Shijia Chen; Jinling Xu; Bingzhen Chen; Hui Chen; Yuwen Wang; Jiawei Zhou; Xudong Yu
Journal:  Front Neurosci       Date:  2021-04-09       Impact factor: 4.677

Review 8.  An updated review about perceptual learning as a treatment for amblyopia.

Authors:  Antonio Rodán; Elena Candela Marroquín; Laura C Jara García
Journal:  J Optom       Date:  2020-11-24

9.  Expression of early growth responsive gene-1 in the visual cortex of monocular form deprivation amblyopic kittens.

Authors:  Haobo Fan; Ying Wang; Xiuping Tang; Liyuan Yang; Weiqi Song; Yunchun Zou
Journal:  BMC Ophthalmol       Date:  2021-11-15       Impact factor: 2.209

10.  Parents' Reported Experiences When Having a Child with Cataract-Important Aspects of Self-Management Obtained from the Paediatric Cataract Register (PECARE).

Authors:  Jenny Gyllén; Gunilla Magnusson; Anna Forsberg
Journal:  Int J Environ Res Public Health       Date:  2020-08-31       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.